Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Plant-based API Market Outlook from 2024 to 2034

The plant-based API market is expected to surge at a CAGR of 6.8% during the projected period. The market value is set to increase from US$ 34.7 billion in 2024 to US$ 67.0 billion by 2034.

Attributes Details
Plant-based API Market Size, 2024 US$ 34.7 billion
Plant-based API Market Size, 2034 US$ 67.0 billion
Value CAGR (2024 to 2034) 6.8%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Plant-Based API Market Overview

The plant-based API products are current dietary trends. They are having deleterious effects on both the environment and human health, with traditional diets being replaced by those characterized by higher intakes of chemical and animal products.

The health benefits of plant-based diets are that these reduce the risk of chronic diseases. Technological advancements have enabled artificial intelligence to develop more sophisticated and efficient plant-based APIs.

Governmental and regulatory bodies implement policies and regulations to encourage sustainability and reduce environmental impact on various industries. This creates a supportive environment for sustainable technology solutions.

The development of applications and software solutions that promote overall well-being provides a way for the plant-based API. The growing demand for plant-based APIs indicates a broader consumption trend as consumers shift toward socially responsible products and services.

Biological diversity, such as herbs, spices, and other natural resources, is becoming mandatory globally. Phytochemicals, which naturally occur as bioactive molecules derived from plants, are adopted in medicinal industries to innovate many medications. Plant-based APIs provide a viable solution to address the rising concerns about climate change and regulatory policies. They align with consumer values and regulatory policies.

Key Opportunities for the Plant-Based API Market

  • The population is moving toward a flexitarian diet, with more varieties of organic products hitting shelves. The popularity of eco-friendly products has been skyrocketing, far beyond just vegetarian and vegan options.
  • Commercially available plant-based ingredients are a high source of protein today. However, the majority of manufacturers only utilize 2% of the 150 plant species that are driving the global food supply chain.
  • Innovating new sources of plant-based protein can help to expand product offerings, which incredibly boosts the taste and texture of the product.
  • Technological advancements make it possible to extract, purify, and synthesize complex compounds from plants. A range of therapeutic options are available that attract traditional pharmaceutical industries and start-ups.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Challenges for the Plant-based API market

Plant-based APIs are products demanded in the market due to their benefits, but the cost of production is higher than other traditional alternatives. This leads to higher consumer prices, impacting market growth.

Consumers are hesitant to adopt alternatives if they do not match the sensory experience of their animal-derived counterparts. The industries have to invest in research and development to improve the taste and texture of their plant-based products and APIs.

The variety of natural and organic products is limited compared to a vast array of traditional animal-based options. The multiplicity of plant-based offerings is expected to limit consumer choice. Additionally, some plant-based ingredients are allergenic for certain humans. Managing allergen concerns and focusing on product safety are challenges for manufacturers

Comparative View of Adjacent Markets

The section involves an examination of various aspects in the comparative analysis of the plant-based API market with other markets such as the specialty active pharmaceutical ingredient market and the antibiotics active pharmaceutical ingredient (API) market.

The plant-based market spreads awareness of the health benefits of natural and organic products, coinciding with the growing interest in the medicinal sector. The manufacturing of specialty as well as antibiotics active pharmaceutical ingredients derived from plants is utilized in various medicinal products. The increasing demand for plant-based products and emphasis on sustainability are predicted to drive the growth of the plant-based API market in the coming years.

Plant-based API market:

Attributes Plant-based API market
Value-based CAGR (2024 to 2034) 6.8%
Market Trend Plant-based products are getting popular in mainstream supermarkets and online platforms
Growth Opportunity Restaurants, cafes, and fast-food chains are adding plant-based options to their menus

Specialty Active Pharmaceutical Ingredient (API) Market:

Attributes Specialty Active Pharmaceutical Ingredient (API) Market
Value-based CAGR (2024 to 2034) 3.2%
Market Trend Advances in biotechnology are aiding the development of specialty APIs for targeted therapies
Growth Opportunity Adoption of precision medicine is creating opportunities for the development of targeted specialty APIs

Antibiotics Active Pharmaceutical Ingredient (API) Market:

Attributes Antibiotics Active Pharmaceutical Ingredient (API) Market
Value-based CAGR (2024 to 2034) 3.3%
Market Trend Concern over antibiotic resistance is driving demand for new and alternative antibiotic APIs
Growth Opportunity Pharmaceutical companies are investing in research and development of novel antibiotic APIs

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category wise insights

The Pharmacological Potential of Alkaloids Makes it a Top Molecule from Plants

In the plant-based API market, alkaloids have a high impact on the pharmacological sector in developing different plant-based medicines.

Attributes Details
Top Molecule type Alkaloids
Market Share in 2024 6.6%
  • The alkaloids have demonstrated an average increase of 8.66 in GBIF occurrences in recent years.
  • Alkaloids are used in marketed medicines, drugs, and clinical environments.
  • There is a growing interest in discovering natural products, especially alkaloids, for therapeutic agents.
  • Plant-based alkaloids are economically important due to their beneficial properties such as medical, nutritional, or industrial value.
  • Alkaloids are crucial for both human medicine and organisms' natural defense mechanisms.
  • Alkaloids, phenols, steroids, carbohydrates, and tannins are some of the plant-important chemical compounds.

The Pharmaceuticals Industry is Leading as the Top End User of Plant-based APIs

The combination of innovation and development, integrating multiple plant proteins for improved texture, taste, and nutritional value, can provide a great opportunity for the API sector. Regulatory support encourages the manufacturing and marketing of plant-based API products, which can positively impact market growth.

Attributes Details
Top End Users Pharmaceuticals
Market Share in 2024 6.4%
  • The pharmaceuticals segment’s dominance is attributed to the rising prevalence of chronic diseases.
  • Plant-based pharmaceuticals give patients faster access to medication.
  • Increasing demand for organic and environmentally friendly plant-based products is rising globally.
  • Health professionals are trying to find plant-based APIs that they consider safer and more beneficial for health.
  • Plant-based APIs offer a more controlled and predictable supply of raw material compared to chemical synthesis.

Country wise insights

Countries Forecasted CAGR from 2024 to 2034
United States 7.1%
United Kingdom 8.0%
China 7.6%
Japan 8.3%
South Korea 9.0%

The United States is Moving to Plant-based Products as People are becoming Health-conscious

  • Animal welfare is increasing the demand for plant-based products in the United States.
  • There is a significant rise in consumer demand for organic and natural products across multiple industries, including pharmaceuticals.
  • The pharmaceutical industry of the United States is the largest and most developed globally.
  • Plant-based APIs focus on consumer preferences in the growing market for natural therapies.
  • Regulatory support promotes the innovation of plant-based products and contributes to market expansion.

The United Kingdom Focuses on Innovation to Meet the Demand for Exclusive Plant-based APIs

  • In the United Kingdom, consumers are adopting vegetarian, vegan, or flexitarian diets.
  • The consumer is more interested in plant-based pharmaceutical and healthcare products.
  • The United Kingdom has a strong pharmaceutical sector which is well known for its development and research capabilities.
  • The government supports pharmaceutical companies in expanding their exploration in the field and provides funding for market expansion in the United Kingdom.

The Promotion of Traditional Medicine and Herbal Remedies in the Healthcare Industries Sparks Market Growth in China

  • China promotes traditional Chinese medicine (TCM) both domestically and internationally. TCM relies on plant-based products, including APIs.
  • Plant-based drugs and APIs are experiencing a surge in investment in research and development by China-based pharmaceutical companies and research institutions.
  • Consumers are moving toward holistic healthcare solutions and demanding plant-based medicines and supplements.
  • Given the side effects of synthetic medications, consumers are shifting toward natural healthcare alternatives.
  • The cultural heritage provides a solid foundation for enriching the plant-based market in China.

Japan’s Focus on Harmony in Health with Plant-based Innovations Fuel Market Expansion

  • Japan-based technology manufacturers process plant protein to generate ingredients like gluten blocks and tofu. This provides a familiar taste and texture for developing new technologies and conducting research.
  • With a parallel decline in meat imports, Japan replicates meat using plant-based sources, which offer a sustainable alternative to animal products.
  • In Japan's food sector, organizations support and benefit from the trend of collaborating with plant-based food manufacturers to offer healthier replacements for consumers.
  • Consumers in Japan are more interested in plant-based dairy alternatives; soy milk, oat milk, and almond milk hold a significant market share.

South Korea is Leading the Alternative Protein Revolution

  • In South Korea, according to the Union of Korean Vegetarians, half a million people strictly follow a vegan diet.
  • Emart, Homeplus, and LotteMart are the most common stores in South Korea offering plant-based products.
  • South Korea is focusing on the innovation and development of plant-based seafood.
  • The country has emerged as a thriving hub of alternative protein innovation.
  • Start-ups manufacturing plant-based pork belly, and the popularization of technology support are signs of administrative support for alternative protein in South Korea.
  • Industries in South Korea have started to innovate in the plant-based sector, including Unlimeat, which has developed meat and seafood alternatives.

Competitive Landscape

Plant-based products are becoming a popular choice due to their health benefits, sustainability, and environmental friendliness. Multiple industry players are collaborating with various research sectors to develop and innovate new plant-based products. Countries are focusing on plant-based APIs to build a strong pharmaceutical background. Expanding product options in the plant-based industry by investing in plant alternatives aims to provide a secure long-term option for consumers.

The growth of eCommerce platforms provides convenient wedges and channels to consumers for multiple accesses to plant-based product collaboration with plant-based APIs. Recent developments in dairy alternatives, such as plant-based milk, cheese, and yogurt, highlight the vegan concept and create opportunities for plant-based APIs used in manufacturing these products.

The aim is to educate consumers about the advantages of a plant-based diet and products that can positively impact market growth. The ability to innovate plant-based products based on consumer preferences and dietary requirements can be a key trend and provide opportunities for API developments.

Recent Developments in the Plant-based API Market

  • In 2023, the Samabrivas platform combined the advantages of plant-based systems and traditional bioproduction in large-scale bioreactors. This permits continuous, reliable, and environmentally sustainable manufacture of a large range of high value all year round.
  • In 2023, Rusan Pharma, a Mumbai-based drug maker that specializes in de-addiction and pain management, launched a new API facility in Prithampu within a special economic zone in Madhya Pradesh.
  • In 2023, India's first API pharmaceutical ingredients fermented unit was established in the Plassara industrial area of Naragarh tehsil.
  • In 2021 the University of Bristol invented a method for the development of a key component of the malaria drug artemisinin using genetically modified yeast. This method serves as an alternative to traditional methods involving extraction from the Artemisia plant.

Key Players

  • Roquette Freres SA
  • EVONIK Industries
  • AG, Cargill, Inc.
  • Novartis AG
  • Sanofi SA
  • Kothari Phytochemicals & Industries Ltd
  • Centroflora Group
  • Arboris, LLCs

Key Segments

By Molecule Type:

  • Alkaloids
  • Phenolic Acids
  • Terpenoids
  • Lignin & Stilbenes
  • Anthocyanin
  • Flavonoids
  • Others

By End Use:

  • Pharmaceuticals
  • Nutraceuticals
  • Herbal Based Industries
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

What is the Expected Value of the Plant-based API Market in 2024?

The plant-based API industry is expected to reach US$ 34.7 billion in 2024.

What is the Projected CAGR for the Plant-based API Market through 2034?

The plant-based API industry is set to expand by a CAGR of 6.8% through 2034.

How much Valuation is Estimated for the Plant-based API Market by 2034?

The plant-based API market is forecasted to reach US$ 67.0 billion by 2034.

Which Country is Expected to Emerge as the Pinnacle of the Plant-based API Market?

South Korea is set to be the top-performing market through 2034, registering a CAGR of 9.0%

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Manufacturer

            3.5.1.2. Mid-Level Participants (Traders)

            3.5.1.3. Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Distributors

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

    4.1. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis, 2019 to 2023

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Tons) Projections, 2024 to 2034

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Molecule Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Molecule Type, 2019 to 2023

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Molecule Type, 2024 to 2034

        5.3.1. Alkaloids

        5.3.2. Phenolic Acids

        5.3.3. Terpenoids

        5.3.4. Lignin & Stilbenes

        5.3.5. Anthocyanin

        5.3.6. Flavonoids

        5.3.7. Others

    5.4. Y-o-Y Growth Trend Analysis By Molecule Type, 2019 to 2023

    5.5. Absolute $ Opportunity Analysis By Molecule Type, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By End-User, 2019 to 2023

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By End-User, 2024 to 2034

        6.3.1. Pharmaceuticals

        6.3.2. Nutraceuticals

        6.3.3. Herbal Based Industries

        6.3.4. Others

    6.4. Y-o-Y Growth Trend Analysis By End-User, 2019 to 2023

    6.5. Absolute $ Opportunity Analysis By End-User, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Region, 2019 to 2023

    7.3. Current Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Region, 2024 to 2034

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. South Asia and Pacific

        7.3.6. East Asia

        7.3.7. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    8.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2019 to 2023

    8.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2024 to 2034

        8.2.1. By Country

            8.2.1.1. USA

            8.2.1.2. Canada

        8.2.2. By Molecule Type

        8.2.3. By End-User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Molecule Type

        8.3.3. By End-User

    8.4. Key Takeaways

9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    9.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2019 to 2023

    9.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2024 to 2034

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Molecule Type

        9.2.3. By End-User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Molecule Type

        9.3.3. By End-User

    9.4. Key Takeaways

10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2019 to 2023

    10.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2024 to 2034

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. UK

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Western Europe

        10.2.2. By Molecule Type

        10.2.3. By End-User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Molecule Type

        10.3.3. By End-User

    10.4. Key Takeaways

11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2019 to 2023

    11.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2024 to 2034

        11.2.1. By Country

            11.2.1.1. Poland

            11.2.1.2. Russia

            11.2.1.3. Czech Republic

            11.2.1.4. Romania

            11.2.1.5. Rest of Eastern Europe

        11.2.2. By Molecule Type

        11.2.3. By End-User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Molecule Type

        11.3.3. By End-User

    11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2019 to 2023

    12.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2024 to 2034

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Bangladesh

            12.2.1.3. Australia

            12.2.1.4. New Zealand

            12.2.1.5. Rest of South Asia and Pacific

        12.2.2. By Molecule Type

        12.2.3. By End-User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Molecule Type

        12.3.3. By End-User

    12.4. Key Takeaways

13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2019 to 2023

    13.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2024 to 2034

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Molecule Type

        13.2.3. By End-User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Molecule Type

        13.3.3. By End-User

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2019 to 2023

    14.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2024 to 2034

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Molecule Type

        14.2.3. By End-User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Molecule Type

        14.3.3. By End-User

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2023

            15.1.2.1. By Molecule Type

            15.1.2.2. By End-User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2023

            15.2.2.1. By Molecule Type

            15.2.2.2. By End-User

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2023

            15.3.2.1. By Molecule Type

            15.3.2.2. By End-User

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2023

            15.4.2.1. By Molecule Type

            15.4.2.2. By End-User

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2023

            15.5.2.1. By Molecule Type

            15.5.2.2. By End-User

    15.6. UK

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2023

            15.6.2.1. By Molecule Type

            15.6.2.2. By End-User

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2023

            15.7.2.1. By Molecule Type

            15.7.2.2. By End-User

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2023

            15.8.2.1. By Molecule Type

            15.8.2.2. By End-User

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2023

            15.9.2.1. By Molecule Type

            15.9.2.2. By End-User

    15.10. Poland

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2023

            15.10.2.1. By Molecule Type

            15.10.2.2. By End-User

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2023

            15.11.2.1. By Molecule Type

            15.11.2.2. By End-User

    15.12. Czech Republic

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2023

            15.12.2.1. By Molecule Type

            15.12.2.2. By End-User

    15.13. Romania

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2023

            15.13.2.1. By Molecule Type

            15.13.2.2. By End-User

    15.14. India

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2023

            15.14.2.1. By Molecule Type

            15.14.2.2. By End-User

    15.15. Bangladesh

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2023

            15.15.2.1. By Molecule Type

            15.15.2.2. By End-User

    15.16. Australia

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2023

            15.16.2.1. By Molecule Type

            15.16.2.2. By End-User

    15.17. New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2023

            15.17.2.1. By Molecule Type

            15.17.2.2. By End-User

    15.18. China

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2023

            15.18.2.1. By Molecule Type

            15.18.2.2. By End-User

    15.19. Japan

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2023

            15.19.2.1. By Molecule Type

            15.19.2.2. By End-User

    15.20. South Korea

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2023

            15.20.2.1. By Molecule Type

            15.20.2.2. By End-User

    15.21. GCC Countries

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2023

            15.21.2.1. By Molecule Type

            15.21.2.2. By End-User

    15.22. South Africa

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2023

            15.22.2.1. By Molecule Type

            15.22.2.2. By End-User

    15.23. Israel

        15.23.1. Pricing Analysis

        15.23.2. Market Share Analysis, 2023

            15.23.2.1. By Molecule Type

            15.23.2.2. By End-User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Molecule Type

        16.3.3. By End-User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Roquette Freres SA

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

                17.1.1.5.2. Product Strategy

                17.1.1.5.3. Channel Strategy

        17.1.2. EVONIK Industries, AG

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

                17.1.2.5.2. Product Strategy

                17.1.2.5.3. Channel Strategy

        17.1.3. Cargill, Inc.

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

                17.1.3.5.2. Product Strategy

                17.1.3.5.3. Channel Strategy

        17.1.4. Novartis AG

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

                17.1.4.5.2. Product Strategy

                17.1.4.5.3. Channel Strategy

        17.1.5. Sanofi SA

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

                17.1.5.5.2. Product Strategy

                17.1.5.5.3. Channel Strategy

        17.1.6. Kothari Phytochemicals & Industries Ltd

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

                17.1.6.5.2. Product Strategy

                17.1.6.5.3. Channel Strategy

        17.1.7. Centroflora Group

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

                17.1.7.5.2. Product Strategy

                17.1.7.5.3. Channel Strategy

        17.1.8. Arboris, LLCs

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

                17.1.8.5.2. Product Strategy

                17.1.8.5.3. Channel Strategy

        17.1.9. BASF SE

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

                17.1.9.5.2. Product Strategy

                17.1.9.5.3. Channel Strategy

        17.1.10. GlaxoSmithKline, plc

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

                17.1.10.5.2. Product Strategy

                17.1.10.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034

Table 2: Global Market Volume (Tons) Forecast by Region, 2019 to 2034

Table 3: Global Market Value (US$ Million) Forecast by Molecule Type, 2019 to 2034

Table 4: Global Market Volume (Tons) Forecast by Molecule Type, 2019 to 2034

Table 5: Global Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 6: Global Market Volume (Tons) Forecast by End-User, 2019 to 2034

Table 7: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 8: North America Market Volume (Tons) Forecast by Country, 2019 to 2034

Table 9: North America Market Value (US$ Million) Forecast by Molecule Type, 2019 to 2034

Table 10: North America Market Volume (Tons) Forecast by Molecule Type, 2019 to 2034

Table 11: North America Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 12: North America Market Volume (Tons) Forecast by End-User, 2019 to 2034

Table 13: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 14: Latin America Market Volume (Tons) Forecast by Country, 2019 to 2034

Table 15: Latin America Market Value (US$ Million) Forecast by Molecule Type, 2019 to 2034

Table 16: Latin America Market Volume (Tons) Forecast by Molecule Type, 2019 to 2034

Table 17: Latin America Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 18: Latin America Market Volume (Tons) Forecast by End-User, 2019 to 2034

Table 19: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 20: Western Europe Market Volume (Tons) Forecast by Country, 2019 to 2034

Table 21: Western Europe Market Value (US$ Million) Forecast by Molecule Type, 2019 to 2034

Table 22: Western Europe Market Volume (Tons) Forecast by Molecule Type, 2019 to 2034

Table 23: Western Europe Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 24: Western Europe Market Volume (Tons) Forecast by End-User, 2019 to 2034

Table 25: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 26: Eastern Europe Market Volume (Tons) Forecast by Country, 2019 to 2034

Table 27: Eastern Europe Market Value (US$ Million) Forecast by Molecule Type, 2019 to 2034

Table 28: Eastern Europe Market Volume (Tons) Forecast by Molecule Type, 2019 to 2034

Table 29: Eastern Europe Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 30: Eastern Europe Market Volume (Tons) Forecast by End-User, 2019 to 2034

Table 31: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 32: South Asia and Pacific Market Volume (Tons) Forecast by Country, 2019 to 2034

Table 33: South Asia and Pacific Market Value (US$ Million) Forecast by Molecule Type, 2019 to 2034

Table 34: South Asia and Pacific Market Volume (Tons) Forecast by Molecule Type, 2019 to 2034

Table 35: South Asia and Pacific Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 36: South Asia and Pacific Market Volume (Tons) Forecast by End-User, 2019 to 2034

Table 37: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 38: East Asia Market Volume (Tons) Forecast by Country, 2019 to 2034

Table 39: East Asia Market Value (US$ Million) Forecast by Molecule Type, 2019 to 2034

Table 40: East Asia Market Volume (Tons) Forecast by Molecule Type, 2019 to 2034

Table 41: East Asia Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 42: East Asia Market Volume (Tons) Forecast by End-User, 2019 to 2034

Table 43: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 44: Middle East and Africa Market Volume (Tons) Forecast by Country, 2019 to 2034

Table 45: Middle East and Africa Market Value (US$ Million) Forecast by Molecule Type, 2019 to 2034

Table 46: Middle East and Africa Market Volume (Tons) Forecast by Molecule Type, 2019 to 2034

Table 47: Middle East and Africa Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 48: Middle East and Africa Market Volume (Tons) Forecast by End-User, 2019 to 2034

List of Charts

Figure 1: Global Market Value (US$ Million) by Molecule Type, 2024 to 2034

Figure 2: Global Market Value (US$ Million) by End-User, 2024 to 2034

Figure 3: Global Market Value (US$ Million) by Region, 2024 to 2034

Figure 4: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034

Figure 5: Global Market Volume (Tons) Analysis by Region, 2019 to 2034

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034

Figure 8: Global Market Value (US$ Million) Analysis by Molecule Type, 2019 to 2034

Figure 9: Global Market Volume (Tons) Analysis by Molecule Type, 2019 to 2034

Figure 10: Global Market Value Share (%) and BPS Analysis by Molecule Type, 2024 to 2034

Figure 11: Global Market Y-o-Y Growth (%) Projections by Molecule Type, 2024 to 2034

Figure 12: Global Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 13: Global Market Volume (Tons) Analysis by End-User, 2019 to 2034

Figure 14: Global Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 15: Global Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 16: Global Market Attractiveness by Molecule Type, 2024 to 2034

Figure 17: Global Market Attractiveness by End-User, 2024 to 2034

Figure 18: Global Market Attractiveness by Region, 2024 to 2034

Figure 19: North America Market Value (US$ Million) by Molecule Type, 2024 to 2034

Figure 20: North America Market Value (US$ Million) by End-User, 2024 to 2034

Figure 21: North America Market Value (US$ Million) by Country, 2024 to 2034

Figure 22: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 23: North America Market Volume (Tons) Analysis by Country, 2019 to 2034

Figure 24: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 25: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 26: North America Market Value (US$ Million) Analysis by Molecule Type, 2019 to 2034

Figure 27: North America Market Volume (Tons) Analysis by Molecule Type, 2019 to 2034

Figure 28: North America Market Value Share (%) and BPS Analysis by Molecule Type, 2024 to 2034

Figure 29: North America Market Y-o-Y Growth (%) Projections by Molecule Type, 2024 to 2034

Figure 30: North America Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 31: North America Market Volume (Tons) Analysis by End-User, 2019 to 2034

Figure 32: North America Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 33: North America Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 34: North America Market Attractiveness by Molecule Type, 2024 to 2034

Figure 35: North America Market Attractiveness by End-User, 2024 to 2034

Figure 36: North America Market Attractiveness by Country, 2024 to 2034

Figure 37: Latin America Market Value (US$ Million) by Molecule Type, 2024 to 2034

Figure 38: Latin America Market Value (US$ Million) by End-User, 2024 to 2034

Figure 39: Latin America Market Value (US$ Million) by Country, 2024 to 2034

Figure 40: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 41: Latin America Market Volume (Tons) Analysis by Country, 2019 to 2034

Figure 42: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 43: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 44: Latin America Market Value (US$ Million) Analysis by Molecule Type, 2019 to 2034

Figure 45: Latin America Market Volume (Tons) Analysis by Molecule Type, 2019 to 2034

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Molecule Type, 2024 to 2034

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Molecule Type, 2024 to 2034

Figure 48: Latin America Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 49: Latin America Market Volume (Tons) Analysis by End-User, 2019 to 2034

Figure 50: Latin America Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 51: Latin America Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 52: Latin America Market Attractiveness by Molecule Type, 2024 to 2034

Figure 53: Latin America Market Attractiveness by End-User, 2024 to 2034

Figure 54: Latin America Market Attractiveness by Country, 2024 to 2034

Figure 55: Western Europe Market Value (US$ Million) by Molecule Type, 2024 to 2034

Figure 56: Western Europe Market Value (US$ Million) by End-User, 2024 to 2034

Figure 57: Western Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 58: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 59: Western Europe Market Volume (Tons) Analysis by Country, 2019 to 2034

Figure 60: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 61: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 62: Western Europe Market Value (US$ Million) Analysis by Molecule Type, 2019 to 2034

Figure 63: Western Europe Market Volume (Tons) Analysis by Molecule Type, 2019 to 2034

Figure 64: Western Europe Market Value Share (%) and BPS Analysis by Molecule Type, 2024 to 2034

Figure 65: Western Europe Market Y-o-Y Growth (%) Projections by Molecule Type, 2024 to 2034

Figure 66: Western Europe Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 67: Western Europe Market Volume (Tons) Analysis by End-User, 2019 to 2034

Figure 68: Western Europe Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 69: Western Europe Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 70: Western Europe Market Attractiveness by Molecule Type, 2024 to 2034

Figure 71: Western Europe Market Attractiveness by End-User, 2024 to 2034

Figure 72: Western Europe Market Attractiveness by Country, 2024 to 2034

Figure 73: Eastern Europe Market Value (US$ Million) by Molecule Type, 2024 to 2034

Figure 74: Eastern Europe Market Value (US$ Million) by End-User, 2024 to 2034

Figure 75: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 76: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 77: Eastern Europe Market Volume (Tons) Analysis by Country, 2019 to 2034

Figure 78: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 79: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 80: Eastern Europe Market Value (US$ Million) Analysis by Molecule Type, 2019 to 2034

Figure 81: Eastern Europe Market Volume (Tons) Analysis by Molecule Type, 2019 to 2034

Figure 82: Eastern Europe Market Value Share (%) and BPS Analysis by Molecule Type, 2024 to 2034

Figure 83: Eastern Europe Market Y-o-Y Growth (%) Projections by Molecule Type, 2024 to 2034

Figure 84: Eastern Europe Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 85: Eastern Europe Market Volume (Tons) Analysis by End-User, 2019 to 2034

Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 88: Eastern Europe Market Attractiveness by Molecule Type, 2024 to 2034

Figure 89: Eastern Europe Market Attractiveness by End-User, 2024 to 2034

Figure 90: Eastern Europe Market Attractiveness by Country, 2024 to 2034

Figure 91: South Asia and Pacific Market Value (US$ Million) by Molecule Type, 2024 to 2034

Figure 92: South Asia and Pacific Market Value (US$ Million) by End-User, 2024 to 2034

Figure 93: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034

Figure 94: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 95: South Asia and Pacific Market Volume (Tons) Analysis by Country, 2019 to 2034

Figure 96: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 97: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 98: South Asia and Pacific Market Value (US$ Million) Analysis by Molecule Type, 2019 to 2034

Figure 99: South Asia and Pacific Market Volume (Tons) Analysis by Molecule Type, 2019 to 2034

Figure 100: South Asia and Pacific Market Value Share (%) and BPS Analysis by Molecule Type, 2024 to 2034

Figure 101: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Molecule Type, 2024 to 2034

Figure 102: South Asia and Pacific Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 103: South Asia and Pacific Market Volume (Tons) Analysis by End-User, 2019 to 2034

Figure 104: South Asia and Pacific Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 105: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 106: South Asia and Pacific Market Attractiveness by Molecule Type, 2024 to 2034

Figure 107: South Asia and Pacific Market Attractiveness by End-User, 2024 to 2034

Figure 108: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034

Figure 109: East Asia Market Value (US$ Million) by Molecule Type, 2024 to 2034

Figure 110: East Asia Market Value (US$ Million) by End-User, 2024 to 2034

Figure 111: East Asia Market Value (US$ Million) by Country, 2024 to 2034

Figure 112: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 113: East Asia Market Volume (Tons) Analysis by Country, 2019 to 2034

Figure 114: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 115: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 116: East Asia Market Value (US$ Million) Analysis by Molecule Type, 2019 to 2034

Figure 117: East Asia Market Volume (Tons) Analysis by Molecule Type, 2019 to 2034

Figure 118: East Asia Market Value Share (%) and BPS Analysis by Molecule Type, 2024 to 2034

Figure 119: East Asia Market Y-o-Y Growth (%) Projections by Molecule Type, 2024 to 2034

Figure 120: East Asia Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 121: East Asia Market Volume (Tons) Analysis by End-User, 2019 to 2034

Figure 122: East Asia Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 123: East Asia Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 124: East Asia Market Attractiveness by Molecule Type, 2024 to 2034

Figure 125: East Asia Market Attractiveness by End-User, 2024 to 2034

Figure 126: East Asia Market Attractiveness by Country, 2024 to 2034

Figure 127: Middle East and Africa Market Value (US$ Million) by Molecule Type, 2024 to 2034

Figure 128: Middle East and Africa Market Value (US$ Million) by End-User, 2024 to 2034

Figure 129: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034

Figure 130: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 131: Middle East and Africa Market Volume (Tons) Analysis by Country, 2019 to 2034

Figure 132: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 133: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 134: Middle East and Africa Market Value (US$ Million) Analysis by Molecule Type, 2019 to 2034

Figure 135: Middle East and Africa Market Volume (Tons) Analysis by Molecule Type, 2019 to 2034

Figure 136: Middle East and Africa Market Value Share (%) and BPS Analysis by Molecule Type, 2024 to 2034

Figure 137: Middle East and Africa Market Y-o-Y Growth (%) Projections by Molecule Type, 2024 to 2034

Figure 138: Middle East and Africa Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 139: Middle East and Africa Market Volume (Tons) Analysis by End-User, 2019 to 2034

Figure 140: Middle East and Africa Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 141: Middle East and Africa Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 142: Middle East and Africa Market Attractiveness by Molecule Type, 2024 to 2034

Figure 143: Middle East and Africa Market Attractiveness by End-User, 2024 to 2034

Figure 144: Middle East and Africa Market Attractiveness by Country, 2024 to 2034

Recommendations

Healthcare

Pharmaceutical Intermediates Market

Published : January 2021

Explore Healthcare Insights

View Reports